Primary analysis showed no significant evidence for a difference in time to end of target lesion primary patency between groups hazard ratio 1.18 with a 95% confidence interval of 0.78 to 1.79. There were no significant differences for any secondary outcomes, including patency outcomes and adverse events. Thus, our study demonstrated no evidence…[Read more]